THE DYSAUTONOMIA PROJECT Second Edition

The Dysautonomia Project is a much-needed tool for clinicians, patients, and caregivers looking to arm themselves with the power of knowledge. It combines current publications from leaders in the field of autonomic disorders with explanations for clinicians and patients about the signs, symptoms, and treatment options.

This Second Edition has been extensively updated, reflecting the most current medical research and findings on dysautonomia over the past decade. It includes new information about many different dysautonomias, a summary of clinical diagnostic guidelines, and new information about patients' experiences of living with autonomic disorders.

Kelly Freeman is the Founder of The Dysautonomia Project and co-author of The Dysautonomia Project Book. Kelly, a dysautonomia patient herself, aims to transform the care of patients with dysautonomia through the education of physicians, patients, and community leaders with the mission of speeding time to diagnosis, proper assessment, and treatment of patients in community-based clinics and hospital settings around the world. After realizing that medical professionals in her own community were lacking knowledge about dysautonomia, Kelly set out to create awareness and education on the community level. This is when The Dysautonomia Project was born. What started as a small vision in May of 2014, has now grown into a large mission to educate our community-based medical professionals and reduce diagnosis time from 6 years to just 15 minutes. Through the distribution of The Dysautonomia Project Book and participation in various community educational events, Kelly Freeman is changing how doctors approach autonomic disorders each and every day.

Dr. David S. Goldstein is a founder and thought leader in autonomic medicine, with substantial experience and expertise in clinical catecholamine neurochemistry, sympathetic neuroimaging, autonomic pathophysiology, mechanisms of catecholaminergic neurodegeneration, and stress and homeostasis as medical scientific ideas. He received his BA from Yale College and M.D.-Ph.D. in Behavioral Sciences from Johns Hopkins. After internal medical residency at the University of Washington he came to the NIH as a Clinical Associate in the NHLBI in 1978, obtaining tenure as a Senior Investigator in 1984. He joined the NINDS in 1990 to head the Clinical Neurochemistry Section and founded the Clinical Neurocardiology Section (name changed to Autonomic Medicine Section in 2019). He retired from the NIH in August, 2025 and now is a Scientist Emeritus. His main strategic goal is to establish autonomic medicine as a clinical and scientific discipline. To pursue this goal, he recently established The Autonomic and Catecholamine Healthspan Institute, LLC.